BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33319858)

  • 21. Updates in Staging and Reporting of Testicular Cancer.
    Magers MJ; Idrees MT
    Surg Pathol Clin; 2018 Dec; 11(4):813-824. PubMed ID: 30447843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic analysis of choriocarcinoma as a pure or predominant component of germ cell tumor of the testis.
    Alvarado-Cabrero I; Hernández-Toriz N; Paner GP
    Am J Surg Pathol; 2014 Jan; 38(1):111-8. PubMed ID: 24145647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk stratification of pubertal children and postpubertal adolescents with clinical stage I testicular nonseminomatous germ cell tumors.
    Cost NG; Lubahn JD; Adibi M; Romman A; Wickiser JE; Raj GV; Sagalowsky AI; Margulis V
    J Urol; 2014 May; 191(5 Suppl):1485-90. PubMed ID: 24679874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interobserver Agreement in Vascular Invasion Scoring and the Added Value of Immunohistochemistry for Vascular Markers to Predict Disease Relapse in Stage I Testicular Nonseminomas.
    Lobo J; Stoop H; Gillis AJM; Looijenga LHJ; Oosterhuis W
    Am J Surg Pathol; 2019 Dec; 43(12):1711-1719. PubMed ID: 31490238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Histopathologic and biological prognostic factors of clinical stage I non-seminomatous germ cell tumors. Implications for risk-adjusted therapy].
    Heidenreich A; Sesterhenn IA; Mostofi FK; Moul JW; Engelmann UH
    Urologe A; 1999 Mar; 38(2):168-78. PubMed ID: 10231939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.
    Sanmamed MF; Esteban E; Uriol E; Zarate R; Capelan M; Muriel C; Crespo G; Berros JP; Pardo-Coto P; Perez Q; Alvarez-Fernández C; Jiménez Fonseca P; Luque M; Astudillo A
    J Transl Med; 2017 Mar; 15(1):62. PubMed ID: 28320414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study.
    Sesterhenn IA; Weiss RB; Mostofi FK; Stablein DM; Rowland RG; Falkson G; Rivkind SE; Vogelzang NJ
    J Clin Oncol; 1992 Jan; 10(1):69-78. PubMed ID: 1309382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microvascular invasion of testicular nonseminomatous germ cell tumors: implications of separate evaluation of lymphatic and blood vessels.
    Heinzelbecker J; Gross-Weege M; Weiss C; Hörner C; Trunk MJ; Erben P; Haecker A; Bolenz C
    J Urol; 2014 Aug; 192(2):593-9. PubMed ID: 24631105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
    Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
    Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical Management of Cervical Non-seminomatous Germ Cell Tumor Metastases.
    Nwosu OI; Jones AJ; Alwani M; Einhorn LH; Moore MG; Mantravadi AV
    Laryngoscope; 2021 Jul; 131(7):1528-1534. PubMed ID: 33421136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.
    Gumus M; Bilici A; Odabas H; Ustaalioglu BBO; Kandemir N; Demirci U; Cihan S; Bayoglu IV; Ozturk T; Turkmen E; Urakci Z; Seker MM; Gunaydin Y; Selcukbiricik F; Turan N; Sevinc A
    World J Urol; 2017 Jul; 35(7):1103-1110. PubMed ID: 27812752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical presentation of testicular germinal cancer].
    Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
    Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. alpha-Catenin expression pattern and DNA image-analysis cytometry have no additional value over primary histology in clinical stage I nonseminomatous testicular cancer.
    Spermon JR; De Wilde PC; Hanselaar AG; Schaafsma HE; Ruijter TE; Witjes JA; Van Moorselaar RJ
    BJU Int; 2002 Feb; 89(3):278-84. PubMed ID: 11856111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical expression of P53 tumor suppressor gene protein in adult germ cell testis tumors: clinical correlation in stage I disease.
    Lewis DJ; Sesterhenn IA; McCarthy WF; Moul JW
    J Urol; 1994 Aug; 152(2 Pt 1):418-23. PubMed ID: 8015085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifocality in testicular germ cell tumor (TGCT): what is the significance of this finding?
    Favilla V; Russo GI; Spitaleri F; Urzì D; Garau M; Madonia M; Saita A; Pirozzi Farina F; La Vignera S; Condorelli R; Calogero AE; Cimino S; Morgia G
    Int Urol Nephrol; 2014 Jun; 46(6):1131-5. PubMed ID: 24318367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between primary tumor pathologic features and presence of clinical metastasis at diagnosis of testicular seminoma.
    Valdevenito JP; Gallegos I; Fernández C; Acevedo C; Palma R
    Urology; 2007 Oct; 70(4):777-80. PubMed ID: 17991554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour: a systematic review and meta-analysis.
    Blok JM; Pluim I; Daugaard G; Wagner T; Jóźwiak K; Wilthagen EA; Looijenga LHJ; Meijer RP; Bosch JLHR; Horenblas S
    BJU Int; 2020 Mar; 125(3):355-368. PubMed ID: 31797520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer.
    Moul JW; McCarthy WF; Fernandez EB; Sesterhenn IA
    Cancer Res; 1994 Jan; 54(2):362-4. PubMed ID: 8275469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of metastatic status in non-seminomatous testicular cancer.
    Ruf CG; Sachs S; Khalili-Harbi N; Isbarn H; Wagner W; Matthies C; Meineke V; Fisch M; Chun FK; Abend M
    World J Urol; 2014 Oct; 32(5):1205-11. PubMed ID: 24166288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of treatment of non-seminomatous tumours of the testis in pathological stage I.
    Wobbes T; Schraffordt Koops H; Oldhoff J; Sleijfer DT; Oosterhuis JW
    Neth J Surg; 1983 Jul; 35(3):89-93. PubMed ID: 6310445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.